T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBL
501
DELISTED
CBL& Associates Properties, Inc.
CBL
| $151M | 0.03% |
7,610,483
-26,436
| -0.3% | -$532K |
|
502
Minerals Technologies
MTX
$2.25B
| $151M | 0.03% |
2,061,027
+47,527
| +2% | +$3.22M |
|
|
DNKN
503
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $149M | 0.03% |
3,142,700
-761,500
| -20% | -$35.3M |
|
504
Matador Resources
MTDR
$6.5B
| $149M | 0.03% |
6,814,963
+1,471,690
| +28% | +$31.7M |
|
|
WRI
505
DELISTED
Weingarten Realty Investors
WRI
| $148M | 0.03% |
4,114,762
-1,114,030
| -21% | -$40.6M |
|
|
IPCC
506
DELISTED
Infinity Property & Casualty C
IPCC
| $147M | 0.03% |
1,794,871
-200
| -0% | -$15.3K |
|
|
EMC
507
DELISTED
EMC CORPORATION
EMC
| $146M | 0.03% |
5,711,459
+1,002,318
| +21% | +$27.6M |
|
508
Radian Group
RDN
$4.87B
| $144M | 0.03% |
8,560,868
+97,770
| +1% | +$1.59M |
|
509
Teledyne Technologies
TDY
$31.8B
| $143M | 0.03% |
1,337,743
+19,280
| +1% | +$1.93M |
|
510
NOV
NOV
$7.45B
| $143M | 0.03% |
2,850,936
+1,380,562
| +94% | +$74.9M |
|
|
HR
511
DELISTED
Healthcare Realty Trust Incorporated
HR
| $142M | 0.03% |
5,126,540
+638,510
| +14% | +$18.2M |
|
512
A.O. Smith
AOS
$8.51B
| $142M | 0.03% |
4,328,960
-1,042,540
| -19% | -$31.7M |
|
513
New York Times
NYT
$10.3B
| $142M | 0.03% |
10,327,400
+2,200
| +0% | +$29.5K |
|
514
Autodesk
ADSK
$52.7B
| $142M | 0.03% |
2,421,805
-1,438,779
| -37% | -$85.2M |
|
515
Semtech
SMTC
$13B
| $142M | 0.03% |
5,322,870
-875,830
| -14% | -$23.9M |
|
516
Innospec
IOSP
$2.29B
| $142M | 0.03% |
3,055,150
-297,580
| -9% | -$12.8M |
|
517
Stratasys
SSYS
$767M
| $142M | 0.03% |
2,682,886
-1,297,161
| -33% | -$85.9M |
|
518
Constellation Brands
STZ
$22.9B
| $140M | 0.03% |
1,200,643
+298,360
| +33% | +$33.6M |
|
|
EPAY
519
DELISTED
Bottomline Technologies Inc
EPAY
| $139M | 0.03% |
5,069,640
+228,990
| +5% | +$5.94M |
|
|
JCP
520
DELISTED
J.C. Penney Company, Inc.
JCP
| $139M | 0.03% |
16,498,367
+915,160
| +6% | +$7.13M |
|
|
EE
521
DELISTED
El Paso Electric Company
EE
| $138M | 0.03% |
3,581,673
-206,827
| -5% | -$7.97M |
|
|
PHH
522
DELISTED
PHH Corporation
PHH
| $138M | 0.03% |
5,711,366
-7,500
| -0.1% | -$181K |
|
523
Scholastic
SCHL
$792M
| $138M | 0.03% |
3,363,660
+409,842
| +14% | +$15.2M |
|
|
TRNX
524
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $137M | 0.03% |
5,222,379
+16,780
| +0.3% | +$425K |
|
525
Archrock
AROC
$5.84B
| $136M | 0.03% |
4,064,762
-853,360
| -17% | -$26M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.